The world's political record
Person
![Official portrait of Rep. Walden, Greg [R-OR-2]](https://www.congress.gov/img/member/w000791_200.jpg)
United States · Official source
1,999 records where Rep. Walden, Greg [R-OR-2] is listed as a sponsor, author, or other actor. Search with topics and years
United States · United States Congress · 7 May 2018
Protecting Seniors From Opioid Abuse Act This bill establishes individuals who are identified as at-risk beneficiaries for prescription drug abuse as qualifying participants in medication therapy management programs under the Medicare prescription drug benefit.
United States · United States Congress · 3 May 2018
This bill requires Medicare prescription drug plan (PDP) sponsors, for plan years beginning on or after January 1, 2021, to establish drug management programs for at-risk beneficiaries. Current law authorizes, but does not require, PDP sponsors to establish such programs.
United States · United States Congress · 3 May 2018
VA Maintaining Internal Systems and Strengthening Integrated Outside Networks Act of 2018 or VA MISSION Act of 2018 This bill consolidates Department of Veterans Affairs (VA) community care programs, revises other VA health care programs and facilities provisions, and makes appropriations for veterans care. The bill establishes the Veterans Community Care Program to furnish hospital care, medical services, and extended care services through certain non-VA providers to veterans who are enrolled in the VA health care system or otherwise entitled to VA care. The VA may enter agreements with non-VA providers to furnish veterans with care that is otherwise not feasibly available. The VA shall: (1) establish standards for VA health care quality and for non-VA care in areas of VA expertise, (2) prohibit rehiring previously-removed VA providers, (3) provide prompt payment to providers, (4) establish opioid prescribing practices for non-VA providers, and (5) carry out the modernization or realignment of Veterans Health Administration facilities. The Veterans Choice Program is terminated after one year. The bill establishes: (1) the Center for Innovation for Care and Payment, and (2) the Asset and Infrastructure Review Commission. The VA may: (1) provide care for the live donor of a transplant for a veteran, and (2) carry out a Specialty Education Loan Repayment Program and other actions to recruit health care professionals. The VA family caregiver program is expanded. The Office of Management and Budget shall review each enhanced-use facility lease. The bill establishes pilot programs for medical scribes, mobile deployment teams for underserved facilities, and graduate medical education. The bill extends VA pension reductions for Medicare-covered veterans in nursing homes.
United States · United States Congress · 1 May 2018
Burn Pits Accountability Act This bill requires the Department of Defense (DOD) and the military departments to evaluate whether each member of the Armed Forces has been (1) based or stationed where an open air burn pit was used to dispose of waste, or (2) exposed to toxic airborne chemicals. Members located where an open burn pit was used or exposed to toxic airborne chemicals must be enrolled in the Airborne Hazards and Open Burn Pit Registry, unless the member elects not to enroll. The evaluations must be included in periodic health assessments, physical exams conducted immediately prior to separation from active duty, and deployment assessments. DOD must share the results of the evaluations with the Department of Veterans Affairs.
United States · United States Congress · 24 April 2018
Advancing High Quality Treatment for Opioid Use Disorders in Medicare Act This bill requires the Centers for Medicare & Medicaid Services (CMS) to carry out a demonstration program to: (1) increase access of opioid use disorder treatment services for Medicare beneficiaries, (2) improve physical and mental health outcomes for such beneficiaries, and (3) reduce Medicare expenditures. Opioid use disorder care teams of practitioners may apply for participation in the demonstration project. The CMS must establish a performance-based incentive payment for participating teams. The CMS must adopt or develop program quality standards and performance methods.
United States · United States Congress · 24 April 2018
Access to Telehealth Services for Opioid Use Disorders Act This bill authorizes the Centers for Medicare & Medicaid Services to waive certain requirements with respect to payment for telehealth services provided to a Medicare beneficiary who is receiving treatment for an opioid-use disorder or a co-occurring mental-health disorder.
United States · United States Congress · 24 April 2018
Opioid Addiction Action Plan Act This bill requires the Centers for Medicare & Medicaid Services (CMS) to develop an action plan to provide recommendations on changes to the Medicare and Medicaid programs to enhance: (1) the treatment and prevention of opioid addiction, and (2) the coverage and reimbursement of medication-assisted treatment for opioid addiction. The CMS must convene a stakeholder meeting to solicit public comment on the action plan.
United States · United States Congress · 23 April 2018
Peer Support Communities of Recovery Act This bill amends the Public Health Service Act to allow the Substance Abuse and Mental Health Services Administration to award grants to nonprofits that focus on substance use disorder to establish regional technical assistance centers to provide assistance regarding implementation of peer-delivered addiction recovery support services, establishment of recovery community organizations and centers, and overdose reversal medication.
United States · United States Congress · 23 April 2018
This bill requires the Centers for Medicare & Medicaid Services to expand its core set of adult health quality measures for Medicaid-eligible adults to include measures specific to behavioral health. A state Medicaid program must report annually on such measures.
United States · United States Congress · 23 April 2018
Abuse Deterrent Access Act of 2018 This bill requires the Centers for Medicare & Medicaid Services to report to Congress on the adequacy of access to abuse-deterrent opioid formulations for individuals with chronic pain enrolled in a prescription drug plan under Medicare or Medicare Advantage (MA). The report must account for any barriers preventing enrollees from accessing such formulations under Medicare or MA.
United States · United States Congress · 23 April 2018
Surveillance and Testing of Opioids to Prevent Fentanyl Deaths Act of 2018 or the STOP Fentanyl Deaths Act of 2018 This bill establishes and expands programs to support increased detection and monitoring of fentanyl and other synthetic opioids, and also establishes a pilot program for point-of-use testing of illicit drugs for dangerous contaminants.
United States · United States Congress · 18 April 2018
Animal Drug and Animal Generic Drug User Fee Amendments of 2018 TITLE I--FEES RELATING TO ANIMAL DRUGS This bill addresses the authority of the Food and Drug Administration (FDA) to collect new animal drug (brand name animal drug) and generic animal drug user fees. Animal Drug User Fee Amendments of 2018 (Sec. 103) The bill amends the Federal Food, Drug, and Cosmetic Act to reauthorize through FY2023 the authority of the FDA to collect and use brand name animal drug user fees. The FDA must not collect fees for (1) supplemental applications that are submitted solely to add the animal drug application number to the label of the drug, and (2) applications for genetically engineered animals that are intended to produce human medical products. The bill revises the total amount of revenue brand name animal drug user fees can generate. The bill also revises the requirements for calculating adjustments to revenue amounts based on changes in the workload for reviewing brand name animal drug applications. (Sec. 104) The bill extends requirements for the FDA to report to Congress on achieving goals related to the animal drug development and review processes and implementation of the authority to collect brand name animal drug user fees. (Sec. 107) The bill terminates the authority of the FDA to collect brand name animal drug user fees on October 1, 2023. TITLE II--FEES RELATING TO GENERIC ANIMAL DRUGS Animal Generic Drug User Fee Amendments of 2018 (Sec. 202) The bill reauthorizes through FY2023 the authority of the FDA to collect and use generic animal drug user fees. The FDA must not collect fees for supplemental abbreviated applications that are submitted solely to add the generic animal drug application number to the label of the drug. The bill revises the total amount of revenue each type of generic animal drug user fee must generate. The bill also revises the requirements for calculating adjustments to revenue amounts based on changes in the workload for reviewing generic animal drug applications. (Sec. 203) The bill extends requirements for the FDA to report to Congress on achieving goals related to the generic animal drug development and review process and the implementation of the authority to collect generic animal drug fees. (Sec. 206) The bill terminates the authority of the FDA to collect generic animal drug user fees on October 1, 2023. TITLE III--MISCELLANEOUS PROVISIONS (Sec. 301) Brand name and generic animal drug applications must be submitted electronically beginning in FY2019. Additionally, applications for conditional approval of brand name animal drugs for minor use and minor species must be submitted electronically beginning in FY2019. (Minor use drugs are for intended uses in major species [horses, dogs, cats, cattle, pigs, turkeys, and chickens] for diseases that occur infrequently or in limited geographic areas and in only a small number of animals annually.) (Sec. 302) Product labeling for certain unapproved brand name animal drugs for minor species must include the index number in order to be marketed. (Sec. 303) The bill prohibits the sale of brand name animal drugs that do not include the FDA application number. (Sec. 304) The bill authorizes the FDA to grant conditional approval of a brand name animal drug not intended for a minor use or minor species if (1) the drug is intended to treat a serious or life-threatening disease or condition or addresses an unmet animal or human health need, and (2) the FDA determines that a demonstration of effectiveness of the drug would require a complex or particularly difficult study or studies. The FDA must issue guidance or regulations that provide further details regarding the criteria for conditional approval. The bill terminates this conditional approval authority on October 1, 2028. The Government Accountability Office must study the effects of the conditional approval pathway for brand name animal drugs. (Sec. 305) The FDA must issue guidance on how to evaluate certain elements of investigations as part of the animal drug application process, and how drug sponsors may obtain feedback from the agency on technical issues before submitting an application. (Sec. 306) The FDA must review investigations conducted in foreign countries when acting on a petition for a food additive intended for use in animal food. The FDA must also issue guidance on the voluntary pre-petition consultation process for such food additives.
United States · United States Congress · 12 April 2018
Special Registration for Telemedicine Clarification Act of 2018 This bill amends the Controlled Substances Act to establish a deadline for the Drug Enforcement Administration to promulgate regulations for the special registration of practitioners to practice telemedicine.
United States · United States Congress · 12 April 2018
Stephen Michael Gleason Congressional Gold Medal Act This bill directs the Speaker of the House of Representatives and the President pro tempore of the Senate to arrange for the award of a Congressional Gold Medal to Stephen Michael Gleason.
United States · United States Congress · 11 April 2018
Better Pain Management Through Better Data Act of 2018 This bill directs the Food and Drug Administration (FDA) to update or issue guidance for drug sponsors on data collection related to the use of other pain medication to reduce the need for opioids. The guidance must address alternative methods for data collection, product labeling, and investigations other than clinical trials.
United States · United States Congress · 11 April 2018
Rural Development of Opioid Capacity Services Act or the Rural DOCS Act This bill requires the Centers for Medicare & Medicaid Services (CMS) to carry out a demonstration project to provide an enhanced federal matching rate for state Medicaid expenditures related to the expansion of substance-use treatment and recovery services. The CMS must select 10 states for inclusion under the demonstration project, giving preference to states that have a prevalence of substance-use disorders (in particular, opioid-use disorders) comparable to or higher than the national average.
United States · United States Congress · 22 March 2018
Children's Hospital GME Support Reauthorization Act of 2018 This bill amends the Public Health Service Act to reauthorize through FY2023 the program that provides payments to children's hospitals that operate graduate medical education programs.
United States · United States Congress · 20 March 2018
Eliminating Opioid Related Infectious Diseases Act of 2018 This bill amends the Public Health Service Act to require the Centers for Disease Control and Prevention to expand its grant program for combating hepatitis C infections to include other infections associated with injection drug use.
United States · United States Congress · 19 March 2018
Poison Center Network Enhancement Act of 2018 This bill amends the Public Health Service Act to reauthorize for FY2020-FY2024 and revise the national toll-free phone number, public awareness campaign, and grant program relating to poison control centers. Among other changes, the bill: supports enhancements of the national toll-free phone number, such as texting capabilities and improved location accuracy; expands the public awareness campaign to include education about information that is available from poison control centers regarding drug misuse; and authorizes poison control centers and professional organizations to use grant funds for preventing and treating the misuse of opioids and other drugs.
United States · United States Congress · 19 March 2018
Comprehensive Opioid Recovery Centers Act of 2018 This bill amends the Public Health Service Act to require the Department of Health and Human Services to award grants to establish or operate comprehensive opioid recovery centers. Priority for grants must be given to entities located in states or Indian country with a high per capita drug overdose mortality rate. Each center must carry out specified outreach activities and specified treatment and recovery services.
United States · United States Congress · 15 March 2018
Ensuring Medicaid Provides Opportunities for Widespread Equity, Resources, and Care Act or the EMPOWER Care Act This bill amends the Deficit Reduction Act of 2005 to extend funding through FY2022 for the Money Follows the Person Rebalancing Demonstration Program and to otherwise revise the program. (Under this program, the Centers for Medicare & Medicaid Services must award grants to state Medicaid programs to assist in rebalancing states' long-term care systems.)
United States · United States Congress · 14 March 2018
Reinforcing Evidence-Based Standards Under Law in Treating Substance Abuse Act of 2018 or the RESULTS Act of 2018 This bill amends the Public Health Service Act to require applicants to demonstrate that a program or activity is evidence-based when applying for support from the Department of Health and Human Services for a program or activity to prevent or treat a mental health or substance use disorder.
United States · United States Congress · 13 March 2018
Treatment, Education, and Community Help to Combat Addiction Act of 2018 or the TEACH to Combat Addiction Act of 2018 This bill amends the Public Health Service Act to require the Department of Health and Human Services to designate Regional Centers of Excellence in Substance Use Disorder Education and provide support to such centers to enhance and improve pain management and substance use disorder education through the distribution of evidence-based curricula for health care professional schools. The bill provides statutory authority for the National Institutes of Health's Centers for Excellence in Pain Education program, under which the centers provide for the coordination of the development, evaluation, and distribution of pain management curricula for health professional schools.
United States · United States Congress · 8 March 2018
Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act or the SCREEN Act This bill amends the Federal Food, Drug, and Cosmetic Act to expand the authority of the Food and Drug Administration to prohibit the importation of certain drugs or destroy illegally imported or hazardous drugs.
United States · United States Congress · 7 March 2018
Alternatives to Opioids (ALTO) in the Emergency Department Act This bill requires the Department of Health and Human Services to carry out a three-year demonstration program awarding grants to hospitals and emergency departments to develop, implement, enhance, or study alternative pain management protocols and treatments that promote limited use of opioids in emergency departments.
United States · United States Congress · 7 March 2018
Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 This bill amends the Controlled Substances Act to allow a pharmacy to deliver a controlled substance to a practitioner, in accordance with a prescription, to be administered to a specific patient for maintenance or detoxification treatment or through an intrathecal pump. The bill directs the Government Accountability Office to report to Congress on access to and the potential diversion of controlled substances administered by injection, implantation, or through the use of an intrathecal pump.
United States · United States Congress · 6 March 2018
Preventing Overdoses While in Emergency Rooms Act of 2018 This bill requires the Department of Health and Human Services to establish a grant program to: (1) develop protocols for discharging patients who are treated for a drug overdose, and (2) enhance the integration and coordination of postdischarge care and treatment options for individuals with a substance use disorder.
United States · United States Congress · 1 March 2018
United States-Israel Security Assistance Authorization Act of 2018 This bill extends Military Financing Program grants for Israel through FY2023. The Department of Defense shall conduct a joint assessment with Israel regarding: (1) precision guided munitions needed by Israel in a sustained armed confrontation with Hezbollah and other armed groups and terrorist organizations, and (2) related U.S. assistance and resupply planning. The President may utilize the Special Defense Acquisition Fund to transfer precision guided munitions and related defense articles and services to reserve stocks for Israel. Authorities for loan guarantees and the war reserves stockpile for Israel are extended through FY2023. The Department of Homeland Security shall establish a seven-year grant program with Israel to support: (1) cybersecurity research and development, and (2) commercialization of cybersecurity technology. The U.S. Agency for International Development may enter into memoranda of understanding with Israel to advance common goals on energy, agriculture and food security, democracy, economic growth, education, and health. The National Aeronautics and Space Administration (NASA) shall continue to work with the Israel Space Agency to pursue peaceful space exploration and science initiatives. The President may enter into a cooperative project agreement with Israel to carry out research and joint production of defense articles and services to detect and destroy unmanned aerial vehicles (i.e., drones) that threaten the United States or Israel. The bill states that it is U.S. policy to ensure that Israel maintains its qualitative military edge.
United States · United States Congress · 1 March 2018
Iranian Revolutionary Guard Corps Economic Exclusion Act This bill expands sanctions against Iran's Islamic Revolutionary Guard Corps (IRGC). The President shall report to Congress regarding: foreign and domestic supply chains that significantly aid the IRGC; Iranian state-owned entities that provide support to terrorist entities, including Mahan Air; and foreign persons owned or controlled by the IRGC, including companies listed on the Tehran Stock Exchange or companies with a value in excess of $100 million. The bill states that it is U.S. policy to prevent Iran's membership in the World Trade Organization and similar international bodies as long as Iran remains a state sponsor of terrorism.
United States · United States Congress · 27 February 2018
Substance Use Disorder Workforce Loan Repayment Act of 2018 This bill amends the Public Health Service Act to create a loan repayment program for individuals who complete a period of service in a substance use disorder treatment job in a mental health professional shortage area or a county where the drug overdose death rate is higher than the national average. The substance use disorder treatment job must be a full-time position where the primary intent and function is the direct care of patients with or in recovery from a substance use disorder. Individuals must enter into an agreement of service of up to six years with the Health Resources and Services Administration. The repayment program shall pay one-sixth of the principal and interest on any eligible loan for each year of service; the maximum total amount of repayment by the program is $250,000 per individual.
United States · United States Congress · 15 February 2018
Safe Disposal of Unused Medication Act This bill amends the Controlled Substances Act to allow a hospice employee to handle controlled substances in the residence of a deceased hospice patient to assist with disposal of the controlled substances.
United States · United States Congress · 13 February 2018
Jessie's Law This bill requires the Department of Health and Human Services (HHS) to develop and disseminate best practices for health care providers and state agencies regarding the display of a patient's history of opioid addiction in the patient's medical records. In doing so, HHS must identify: (1) the circumstances under which information provided by a patient to a health care provider should, upon patient request, be displayed in the patient's medical records; (2) what constitutes a patient request; and (3) the process and methods by which the information should be displayed.
United States · United States Congress · 13 February 2018
Advancing Cutting Edge Research Act or the ACE Research Act This bill amends the Public Health Service Act to expand the National Institutes of Health's unique research initiatives to include cutting-edge research that: (1) fosters scientific creativity and increases fundamental biological understanding leading to the prevention, diagnosis, or treatment of diseases and disorders; or (2) is urgently required to respond to a public health threat. (Unique research initiatives may be supported through transactions other than contracts, grants, or cooperative agreements.)
United States · United States Congress · 13 February 2018
Health Insurance for Former Foster Youth Act This bill requires state Medicaid programs to expand coverage for former foster care youth. Specifically, state Medicaid programs must cover individuals who were in foster care at 14 years of age but who subsequently left foster care due to a kinship guardianship. In addition, states must provide such coverage regardless of whether individuals were enrolled in Medicaid while in foster care.
United States · United States Congress · 8 February 2018
FCC Reauthorization Act of 2018 This bill reauthorizes the Federal Communications Commission (FCC) for FY2019-FY2020. It amends the Communications Act of 1934 to require that FCC-collected fees be deposited and credited as offsetting collections. Regulatory and application fees must be assessed at rates to recover costs associated with such activities. The bill requires the Department of the Treasury to accept bidding deposits for spectrum auctions held by the FCC. The deposits of successful bidders must be used for deficit reduction. The bill includes requiring the FCC: to complete a rulemaking proceeding and adopt procedural changes to maximize opportunities for public participation and efficient decision-making; to amend station antenna structure regulations to prohibit certain private land use restrictions from applying to amateur radio stations; and to submit a study on the public safety benefits, technical feasibility, and cost of providing the public with access to 9-1-1 services during times of emergency when mobile service is unavailable. Specified providers that offer the capability to transmit voice communications and signaling information from one destination to another, and that charge a rate to any other entity for such a transmission, must register with the FCC and comply with service quality standards to be established by the FCC. The bill applies the prohibition against knowingly transmitting misleading or inaccurate caller identification information to text messages and persons outside the United States if the recipient is within the United States. Communications networks must be treated as critical infrastructure and protected systems under the Homeland Security Act of 2002.
United States · United States Congress · 30 January 2018
Student, Teachers, and Officers Preventing School Violence Act of 2018 or the STOP School Violence Act of 2018 This bill amends the Omnibus Crime Control and Safe Streets Act of 1968 to revise and reauthorize through FY2028 the Secure Our Schools grant program. This grant program provides grants to states, local governments, and Indian tribes to improve security, including the placement and use of metal detectors and other deterrent measures, at schools and on school grounds.
United States · United States Congress · 25 January 2018
Precision Agriculture Connectivity Act of 2018 This bill requires the Federal Communications Commission to establish the Task Force for Meeting Connectivity and Technology Needs of Precision Agriculture in the United States. The task force's duties include: (1) identifying and measuring current gaps in broadband Internet access service coverage of cropland and ranchland; (2) assembling a comprehensive guide of all federal programs and resources working to expand broadband Internet access service on unserved cropland and ranchland; and (3) developing policy recommendations to promote the rapid, expanded deployment of fixed and mobile broadband Internet access service on unserved cropland and ranchland.
United States · United States Congress · 18 January 2018
Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018 This bill requires Medicare's electronic-prescription program to provide for the secure electronic transmittal of a prior authorization request from a Medicare enrollee's prescribing health-care professional with respect to a drug covered under the Medicare prescription drug benefit.
United States · United States Congress · 11 January 2018
Honors: (1) Mark E. Miller for his distinguished public service and professional assistance to Congress, and (2) the Medicare Payment Advisory Commission for its 20 years of professionalism and dedication in its assistance in shaping Medicare policy.
United States · United States Congress · 19 December 2017
Ensuring Access to Quality Sober Living Act of 2017 This bill requires the Substance Abuse and Mental Health Services Administration to publish best practices for operating recovery housing, to distribute such publication to the states, and to provide technical assistance to states seeking to adopt such practices. "Recovery housing" means a shared living environment free from alcohol and illegal drug use and centered on peer support and connection to services to promote recovery from substance use disorders.
United States · United States Congress · 1 December 2017
This bill amends title XXI (Children's Health Insurance Program [CHIP]) of the Social Security Act to establish a special rule, with respect to the first quarter of FY2018, for the redistribution of unused CHIP allotments to state child health plans experiencing emergency shortfalls. Specifically, the Centers for Medicare & Medicaid Services (CMS) must redistribute unused allotments to each such state in an amount equal to the state's emergency shortfall before the CMS may redistribute the allotments to any state that is experiencing a nonemergency shortfall.
United States · United States Congress · 30 November 2017
Congressional Accountability and Hush Fund Elimination Act This bill amends the Congressional Accountability Act of 1995 (CAA) to (1) prohibit the use of public funds for payments of awards and settlements resulting from violation of certain CAA rights and protections if the violation consists of sexual harassment or sexual assault, (2) prohibit an imposition of a nondisclosure agreement as a prerequisite for CAA procedures to consider the violation, and (3) permit an individual to publicize any information relating to such a prior award or settlement if it was conditioned on a nondisclosure agreement.
United States · United States Congress · 15 November 2017
Moving Americans Privacy Protection Act This bill amends the Tariff Act of 1930 to revise requirements regarding the public disclosure of personally identifiable information contained in the manifest of vessels or aircraft entering any U.S. port or place to direct the U.S. Customs and Border Protection (CBP) to ensure that any such information, including social security numbers, passport numbers, and residential addresses, are removed from any manifest signed and transmitted to the CBP before it is disclosed to the public.
United States · United States Congress · 13 November 2017
This bill amends the Federal Food, Drug, and Cosmetic Act to allow the Food and Drug Administration (FDA) to authorize the emergency use of an otherwise unapproved medical product if the Department of Defense (DOD) determines that there is a military emergency involving an agent that may cause imminently life-threatening and specific risk to U.S. forces. If a military emergency is determined to exist, the bill allows DOD to request that the FDA expedite certain procedures for approving medical products that would be reasonably likely to diagnose, prevent, treat, or mitigate such risk. The FDA must take specified actions to facilitate such a request by DOD. The bill repeals provisions of the National Defense Authorization Act for Fiscal Year 2018 that allow DOD, rather than the FDA, to authorize the emergency use of an unapproved product under similar circumstances. Unless DOD determines such meetings to be unnecessary, the FDA shall meet with DOD: (1) semi-annually to conduct a full review of relevant medical products in the DOD portfolio; and (2) quarterly to discuss the development status of regenerative medicine advanced therapy, blood, and vaccine medical products and projects that DOD prioritizes.
United States · United States Congress · 9 November 2017
Veteran Treatment Court Coordination Act of 2017 This bill expresses the sense of Congress that veterans treatment courts are a successful program aimed at helping veterans charged with non-violent crimes receive the help and the benefits to which they are entitled. The Department of Justice (DOJ) shall establish a Veteran Treatment Court Program to provide assistance to state circuit court systems that have adopted or filed a notice of intent to establish such a program. The DOJ program shall include veterans treatment court grant programs carried out pursuant to laws establishing other incarceration alternatives programs.
United States · United States Congress · 9 November 2017
Klamath Infrastructure Improvement Act This bill amends the Klamath Basin Water Supply Enhancement Act of 2000 to authorize the Department of the Interior to carry out activities, including entering into contracts or making financial assistance available, to: (1) plan, implement, and administer programs to align water supplies and demand for irrigation water users associated with the Klamath Project (Bureau of Reclamation project in California and Oregon), with a primary emphasis on programs developed or endorsed by local entities comprised of representatives of those water users; (2) plan and implement activities and projects that avoid or mitigate environmental effects of irrigation activities or that restore habitats in the Klamath Basin watershed; and (3) limit the net delivered cost of power for covered power uses. "Covered power use" means a use of power to develop or manage water from any source for irrigation, wildlife purposes, or drainage on land that is: (1) associated with the Klamath Project; or (2) irrigated by the class of users covered by the agreement dated April 30, 1956, between the California Oregon Power Company and Klamath Basin Water Users Protective Association and within the Off Project Area. Interior must submit a report to Congress that identifies the power cost benchmark (the average net delivered cost of power for irrigation and drainage at reclamation projects in the area surrounding the Klamath Project that are similarly situated to the project). The replacement of the C Canal flume within the Klamath Project shall be considered to be, and shall receive the treatment authorized for, qualified emergency extraordinary operation and maintenance work in accordance with federal reclamation law.
United States · United States Congress · 7 November 2017
Indexing Narcotics, Fentanyl, and Opioids Act of 2017 or the INFO Act This bill requires the Secretary of Health and Human Services to appoint a federal coordinator within the Department of Health and Human Services to: coordinate programs related to opioid abuse reduction, liaise with state and local entities carrying out activities relating to opioid abuse reduction, and establish and operate a publicly available electronic database to facilitate data collection related to opioid abuse .
United States · United States Congress · 7 November 2017
Empowering Pharmacists in the Fight Against Opioid Abuse Act This bill requires the Drug Enforcement Administration (DEA) to develop and disseminate training programs and materials on: (1) the circumstances under which a pharmacist may refuse to fill a controlled substance prescription suspected to be fraudulent, forged, or indicative of abuse or diversion; and (2) federal requirements related to such refusal. The DEA must seek input from relevant stakeholders.
United States · United States Congress · 26 October 2017
Honors the Portland Thorns FC as the 2017 champions of the National Women's Soccer League.
United States · United States Congress · 24 October 2017
USS Indianapolis Congressional Gold Medal Act This bill requires the House of Representatives and the Senate to make appropriate arrangements for the award, on behalf of Congress, of a single gold medal of appropriate design to the crew of the USS Indianapolis, in recognition of their perseverance, bravery, and service. Following the award of the gold medal, it shall be given to the Indiana War Museum in Indianapolis, Indiana, where it will be displayed and made available for research. The bill expresses the sense of Congress that the Indiana War Memorial Museum should make the gold medal available for display elsewhere, particularly at other locations and events associated with the USS Indianapolis.